Oral topotecan utilization for a metronomic dosing schedule to treat recurrent or persistent solid tumors.
Phase of Trial: Phase I/II
Latest Information Update: 19 Jul 2013
At a glance
- Drugs Topotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 17 Jul 2013 Primay endpoint amended as reported by ClinicalTrials.gov.
- 06 Jul 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.